Remove HIPAA Remove Labelling Remove Webinar
article thumbnail

Pharma Email Marketing Solutions for Large Lists

Pharma Marketing Network

For starters, every email must comply with HIPAA, CAN-SPAM, and FDA regulations. Missteps in off-label promotion or data security can trigger legal and reputational risks. Large pharma email marketing programs often pull from multiple databases: CRM records, rep interactions, webinar registrants, and more.

HIPAA 52
article thumbnail

Email Marketing Campaigns for Pharma: Boost Engagement & Compliance

Pharma Marketing Network

Challenges in Pharma Email Marketing Pharma brands face unique barriers that other industries dont , such as: Strict compliance regulations (FDA, GDPR, HIPAA) that limit messaging. Drug names and indications must align with FDA-approved labeling. signing up for a webinar, downloading a whitepaper)? Ideal: 2-5% CTR ).

HIPAA 72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Clarify What Information is Sought from Speakers Report on Data Utilization Host Educational Webinars Before Listening Sessions Market as Stakeholder Listening Sessions if They Have Broader Representation Improve the Structure of the Listening Sessions. Finally, we encourage CMS to consider a longer time horizon for the submission of data.

article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

FDA Law Blog: Biosimilars

Hull & JP Ellison At our webinar earlier this month, we talked about Administration priorities as they relate to the FDC Act and noted that we expect much to remain the same with respect to enforcement. Were not trying to bury the lead here, but the battle of labeling these surgical and drug treatments is a political one.